(RVMD) Revolution Medicines - Performance 3.3% in 12m
Compare RVMD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
11.85%
#29 in Group
Rel. Strength
51.26%
#3901 in Universe
Total Return 12m
3.25%
#48 in Group
Total Return 5y
27.17%
#33 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -12.65%
(?) Percentile in Group
12m Total Return: RVMD (3.3%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: RVMD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RVMD
Total Return (including Dividends) | RVMD | XBI | S&P 500 |
---|---|---|---|
1 Month | -4.83% | -10.94% | -6.73% |
3 Months | -8.99% | -14.92% | -11.93% |
12 Months | 3.25% | -6.46% | 7.24% |
5 Years | 27.17% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | RVMD | XBI | S&P 500 |
1 Month | -2.20% | -52.8% | -63.5% |
3 Months | -88.1% | -92.8% | -90.3% |
12 Months | -2.20% | -32.4% | 60.6% |
5 Years | 16.1% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #74 | 6.87% | 2.04% |
3 Month | #57 | 6.97% | 3.33% |
12 Month | #49 | 10.4% | -3.71% |
5 Years | #33 | 57.4% | -36.6% |
FAQs
Does RVMD Revolution Medicines outperforms the market?
Yes,
over the last 12 months RVMD made 3.25%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months RVMD made -8.99%, while XBI made -14.92%.
Over the last 3 months RVMD made -8.99%, while XBI made -14.92%.
Performance Comparison RVMD vs Indeces and Sectors
RVMD vs. Indices RVMD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.57% | 1.90% | -16.1% | -3.99% |
US NASDAQ 100 | QQQ | 1.09% | 2.53% | -16.2% | -4.34% |
US Dow Jones Industrial 30 | DIA | 3.60% | 2.08% | -16.7% | -1.24% |
German DAX 40 | DAX | 0.35% | -0.89% | -36.0% | -17.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.14% | -1.44% | -17.2% | -5.96% |
Hongkong Hang Seng | HSI | -1.10% | -1.11% | -20.6% | -13.5% |
India NIFTY 50 | INDA | -0.58% | -6.86% | -19.4% | 0.26% |
Brasil Bovespa | EWZ | -2.70% | -5.29% | -21.1% | 12.0% |
RVMD vs. Sectors RVMD is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.86% | 2.02% | -25.2% | -11.8% |
Consumer Discretionary | XLY | 0.13% | 2.01% | -21.4% | -8.04% |
Consumer Staples | XLP | 1.42% | -7.81% | -24.0% | -8.08% |
Energy | XLE | 1.50% | 7.67% | -14.8% | 16.0% |
Financial | XLF | 0.87% | 0.02% | -24.9% | -14.6% |
Health Care | XLV | 3.84% | 2.93% | -13.8% | 5.64% |
Industrial | XLI | 2.17% | 1.20% | -15.9% | -0.81% |
Materials | XLB | 1.83% | 1.02% | -8.79% | 9.17% |
Real Estate | XLRE | 1.80% | -1.60% | -15.7% | -11.5% |
Technology | XLK | 1.30% | 4.17% | -9.81% | 2.09% |
Utilities | XLU | 1.68% | -5.03% | -19.7% | -18.4% |
Aerospace & Defense | XAR | 3.02% | -1.65% | -25.4% | -18.6% |
Biotech | XBI | -1.85% | 6.11% | -4.65% | 9.71% |
Homebuilder | XHB | 0.04% | 3.29% | -1.29% | 13.8% |
Retail | XRT | -0.30% | 0.56% | -12.6% | 9.54% |